4.6 Article

Angiogenic cytokines and their influence on circulating tumour cells in sera of patients with the primary diagnosis of breast cancer before treatment

Related references

Note: Only part of the references are listed.
Review Pharmacology & Pharmacy

Placental growth factor in cancer

Mieke Dewerchin et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2014)

Review Biochemistry & Molecular Biology

Anti-Vascular Endothelial Growth Factor Therapy in Breast Cancer

Tina Bogelund Kristensen et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)

Article Oncology

Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients

Brigitte Rack et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)

Article Oncology

Depression, cytokines, and pancreatic cancer

William Breitbart et al.

PSYCHO-ONCOLOGY (2014)

Article Biotechnology & Applied Microbiology

Combining virotherapy and angiotherapy for the treatment of breast cancer

M. Bazan-Peregrino et al.

CANCER GENE THERAPY (2013)

Review Biochemistry & Molecular Biology

Biomarkers for Anti-Angiogenic Therapy in Cancer

Markus Wehland et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)

Article Multidisciplinary Sciences

Tumor cell-derived placental growth factor sensitizes antiangiogenic and antitumor effects of anti-VEGF drugs

Eva-Maria Eleonora Hedlund et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Medicine, Research & Experimental

Delivery of Soluble VEGF Receptor 1 (sFlt1) by Gene Electrotransfer as a New Antiangiogenic Cancer Therapy

Julien Verrax et al.

MOLECULAR PHARMACEUTICS (2011)

Article Oncology

Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer

Edoardo Botteri et al.

BREAST CANCER RESEARCH AND TREATMENT (2010)

Article Biotechnology & Applied Microbiology

Blood outgrowth endothelial cell-based systemic delivery of antiangiogenic gene therapy for solid tumors

V. Bodempudi et al.

CANCER GENE THERAPY (2010)

Review Pharmacology & Pharmacy

Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy

Gang Niu et al.

CURRENT DRUG TARGETS (2010)

Article Oncology

Angiogenic Balance in Pregnancy and Subsequent Breast Cancer Risk and Survival: A Population Study

Lars J. Vatten et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)

Review Oncology

Placental ischemia and breast cancer risk after preeclampsia: tying the knot

Anne Gingery et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2009)

Article Multidisciplinary Sciences

Malignant cell-derived PlGF promotes normalization and remodeling of the tumor vasculature

Eva-Maria Hedlund et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Review Oncology

The angiogenic switch in carcinogenesis

Vanessa Baeriswyl et al.

SEMINARS IN CANCER BIOLOGY (2009)

Article Biochemistry & Molecular Biology

Anti-PIGF inhibits growth of VEGF(R)-Inhibitor-Resistant tumors without affecting healthy vessels

Christian Fischer et al.

Article Biochemistry & Molecular Biology

Angiogenic factors and preeclampsia

May Lee Tjoa et al.

FRONTIERS IN BIOSCIENCE-LANDMARK (2007)

Review Oncology

Pro-angiogenic cytokines and their role in tumor angiogenesis

Gera Neufeld et al.

CANCER AND METASTASIS REVIEWS (2006)

Article Medicine, General & Internal

Circulating angiogenic factors and the risk of preeclampsia

RJ Levine et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Article Medicine, General & Internal

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

M Cristofanilli et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Review Endocrinology & Metabolism

Vascular endothelial growth factor: Basic science and clinical progress

N Ferrara

ENDOCRINE REVIEWS (2004)

Article Cardiac & Cardiovascular Systems

Blockage of VEGF-induced angiogenesis by preventing VEGF secretion

M Björndahl et al.

CIRCULATION RESEARCH (2004)